Epirium Bio has a total of 41 patents globally, out of which 13 have been granted. Of these 41 patents, more than 73% patents are active. United States of America is where Epirium Bio has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Epirium Bio.
Epirium Bio was founded in the year 2017. The Company is a clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease.
Do read about some of the most popular patents of Epirium Bio which have been covered by us in this article and also you can find Epirium Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Epirium Bio patent portfolio.
How many patents does Epirium Bio have?
Epirium Bio has a total of 41 patents globally. These patents belong to 18 unique patent families. Out of 41 patents, 30 patents are active.
How Many Patents did Epirium Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Epirium Bio Applications Filed | Epirium Bio Patents Granted |
| 2023 | 1 | 1 |
| 2022 | 6 | 1 |
| 2021 | 5 | 4 |
| 2020 | 3 | 1 |
| 2019 | 12 | – |
| 2018 | 1 | 3 |
| 2017 | 2 | 1 |
| 2016 | – | 1 |
| 2015 | 1 | 1 |
| 2014 | 6 | – |
| 2013 | 1 | – |
| 2012 | 3 | – |
How many Epirium Bio patents are Alive/Dead?
How Many Patents did Epirium Bio File in Different Countries?
Countries in which Epirium Bio Filed Patents
| Country | Patents |
| United States Of America | 18 |
| Europe | 4 |
| Australia | 3 |
| Canada | 3 |
| Brazil | 2 |
| Israel | 2 |
| China | 2 |
| Austria | 1 |
| Germany | 1 |
| Argentina | 1 |
| Taiwan | 1 |
Where are Research Centres of Epirium Bio Patents Located?
10 Best Epirium Bio Patents
US20150376225A1 is the most popular patent in the Epirium Bio portfolio. It has received 18 citations so far from companies like Sage Therapeutics, Inc., Aska Pharmaceutial Co., Ltd. and Hunan Huacheng Biological Resources Co., Ltd.
Below is the list of 10 most cited patents of Epirium Bio:
| Publication Number | Citation Count |
| US20150376225A1 | 18 |
| US9901564B2 | 4 |
| US10052316B2 | 3 |
| US20190262347A1 | 3 |
| US10898465B2 | 2 |
| WO2022082009A1 | 2 |
| US11273144B2 | 1 |
| US10618933B2 | 1 |
| US9556140B2 | 1 |
| US9428482B2 | 1 |
What Percentage of Epirium Bio US Patent Applications were Granted?
Epirium Bio (Excluding its subsidiaries) has filed 16 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 73.33%.
Below are the key stats of Epirium Bio patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Epirium Bio?
| Law Firm | Total Applications | Success Rate |
| Morrison & Foerster Llp | 14 | 76.92% |
| Foley Hoag Llp General | 1 | 100.00% |
| Leydig Voit & Mayer Ltd | 1 | 0.00% |
List of Epirium Bio Patents
| Epirium Bio Patents | Title |
| US11542298B2 | Hydroxysteroid Compounds, Their Intermediates, Process Of Preparation, Composition And Uses Thereof |
| US11273144B2 | Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders |
| US11154546B2 | Methods And Compositions For Treatment Of Mitochondrial Toxicity |
| US10898465B2 | Utility Of (+) Epicatechin And Their Analogs |
| US10618933B2 | Hydroxysteroid Compounds, Their Intermediates, Process Of Preparation, Composition And Uses Thereof |
| US10052316B2 | Methods And Compositions For Treatment Of Mitochondrial Toxicity |
| US9975869B2 | Analogues Of Epicatechin And Related Polyphenols |
| US9901564B2 | Compounds And Compositions For The Treatment Of Muscular Disorders |
| US9556140B2 | Approach For Synthesis Of Catechins |
| US9428482B2 | Process For Synthesis Of Polyphenols |
| US9187448B2 | Flavonoid Compounds |
| US20230250131A1 | Hydroxysteroid Compounds |
| US20230192638A1 | Polyphenols Derivatives |
| US20220401409A1 | Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders |
| EP2948437B1 | Approach For Synthesis Of Catechins |
| EP4228650A1 | Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof |
| CN113227067A | Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former |
| CN111989098A | Compounds And Compositions For Treatment Of Muscular Disorders |
| WO2023009642A1 | Pyrrolo[2,3-B]Pyridine Pgdh Inhibitors And Methods Of Making And Using |
| WO2023009618A1 | Bicyclic Pgdh Inhibitors And Methods Of Making And Using |
| DE602014081026T2 | Process For The Synthesis Of Catechins |
| CA3195859A1 | Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof |
| CA3117466A1 | Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former |
| CA3091892A1 | Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders |
| AU2021361071A1 | Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof |
| AU2019224003A1 | Compounds And Compositions For The Treatment Of Muscular Disorders |
| IL282571A | Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former |
| IL276786A | Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders |
| AR126584A1 | Pyrrolo[2,3-B]Pyridine Pgdh Inhibitors And Methods Of Making And Using Them |
| TW202310836A | Pyrrolo[2,3-B]Pyridine Pgdh Inhibitors And Methods Of Making And Using |
| US20210380535A1 | Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former |
| US20210177801A1 | Utility Of (+) Epicatechin And Their Analogs |
| US20190262347A1 | Composition Comprising Combination Of Epicatechin And Anti-Cancer Compound |
| US20150376225A1 | Novel Compounds Of 11Beta-Hydroxy-Steroids For Use In Mitochondria Biogenesis And Diseases Associated With Mitochondrial Dysfunction Or Depletion |
| EP3755319A4 | Compounds And Compositions For The Treatment Of Muscular Disorders |
| EP3870571A1 | Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former |
| WO2022082009A1 | Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof |
| AU2019363595A1 | Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former |
| BR112021007684A2 | Cocrystal, Pharmaceutical Composition, Methods For Treatment Of A Disease Or Disorder That Would Benefit From Modification Of The Electron Transport Chain, To Reduce Triglyceride Levels, To Treat A Disease Or Disorder Selected From The Group Consisting Of A Dietabolic Syndrome, Type Ii, A Congenital Hyperlipidemia And Drug-Induced Hyperlipidemia, To Treat A Condition Related To Mitochondrial Dysfunction, To Improve Sports Performance, Endurance, Building Form Or Muscle Strength, Or To Facilitate Recovery From The Effects Of Training Or Competition, And To Treat Preventing Dystrophinopathy, Sarcoglycanopathy Or Dysferlinopathy, Process For Preparing A Co-Crystal, And, Use Of A Co-Crystal |
| BR112020016923A2 | A Method For Reversing Or Mitigating Injury, Or Bone Weakness Or Loss, Or For Avoiding Fractures In An Individual, And, Composition |
| AT1443865T | Process For The Synthesis Of Catechins |
What are Epirium Bio key innovation segments?
What Technologies are Covered by Epirium Bio?
The chart below distributes patents filed by Epirium Bio